LIYA THOMAS: Open Payments
NPI 1538890157 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,881 in 219 payments from 17 companies in 2025. Trend: 2023 $162 · 2024 $3,508 · 2025 $3,881
Food & beverage: $3,782Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $705 |
| Janssen Biotech, Inc. | 36 | $612 |
| GENZYME CORPORATION | 14 | $434 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $369 |
| Novartis Pharmaceuticals Corporation | 24 | $344 |
| Regeneron Healthcare Solutions, Inc. | 10 | $296 |
| PFIZER INC. | 20 | $261 |
| Incyte Corporation | 20 | $245 |
| UCB, Inc. | 16 | $207 |
| Lilly USA, LLC | 6 | $129 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, OPZELURA, COSENTYX, ILUMYA, Bimzelx.
Industry payments across NY — which companies pay providers there.
